Back

Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Basic science e-posters Drugs, Drug Targets ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Dean Gilham

Resverlogix Corp., Calgary (Canada)

202 More presentations in this session

Presentation thumbnail
Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress
Doctor T. Yamamoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes
Doctor C. Lo (Miaoli, TW)
Abstract Slides
Presentation thumbnail
Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense
Professor I. Andreadou (Athens, GR)
Abstract Slides
Presentation thumbnail
Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides
Presentation thumbnail
Melatonin receptor blockade slows ventricular conduction by IK1 downregulation
Doctor M. Gonotkov (Syktyvkar, RU)
Abstract Slides

Access the full session

Session thumbnail
Basic science e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
The BET inhibitor Apabetalone protects against heart failure with preserved ejection fraction by suppressing myocardial inflammation
1 September 2024
thumbnail
Congress Presentation
Early detection of exacerbation of the severe acute respiratory syndrome coronavirus 2 infection using Fitbit (DEXTERITY Pilot Study)
27 August 2021
thumbnail
Congress Presentation
Cardioprotective effect of angiotensin converting enzyme 2 activation in hESC-derived cardiomyocytes under diabetic condition
21 May 2023
thumbnail
Congress Presentation
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources